Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

The multiple functions of the numerous Chlamydia trachomatis secreted proteins: the tip of the iceberg.

Bugalhão JN, Mota LJ.

Microb Cell. 2019 Aug 21;6(9):414-449. doi: 10.15698/mic2019.09.691. Review.

2.

CteG is a Chlamydia trachomatis effector protein that associates with the Golgi complex of infected host cells.

Pais SV, Key CE, Borges V, Pereira IS, Gomes JP, Fisher DJ, Mota LJ.

Sci Rep. 2019 Apr 16;9(1):6133. doi: 10.1038/s41598-019-42647-3.

3.

SsaV Interacts with SsaL to Control the Translocon-to-Effector Switch in the Salmonella SPI-2 Type Three Secretion System.

Yu XJ, Grabe GJ, Liu M, Mota LJ, Holden DW.

MBio. 2018 Oct 2;9(5). pii: e01149-18. doi: 10.1128/mBio.01149-18.

4.

The Human Centrosomal Protein CCDC146 Binds Chlamydia trachomatis Inclusion Membrane Protein CT288 and Is Recruited to the Periphery of the Chlamydia-Containing Vacuole.

Almeida F, Luís MP, Pereira IS, Pais SV, Mota LJ.

Front Cell Infect Microbiol. 2018 Jul 26;8:254. doi: 10.3389/fcimb.2018.00254. eCollection 2018.

5.

Effector Translocation Assay: Differential Solubilization.

Franco IS, Pais SV, Charro N, Mota LJ.

Methods Mol Biol. 2017;1615:501-515. doi: 10.1007/978-1-4939-7033-9_35.

PMID:
28667633
6.

The Chlamydia trachomatis type III secretion substrates CT142, CT143, and CT144 are secreted into the lumen of the inclusion.

da Cunha M, Pais SV, Bugalhão JN, Mota LJ.

PLoS One. 2017 Jun 16;12(6):e0178856. doi: 10.1371/journal.pone.0178856. eCollection 2017.

7.

In Vitro Activity of Quaternary Ammonium Surfactants against Streptococcal, Chlamydial, and Gonococcal Infective Agents.

Inácio ÂS, Nunes A, Milho C, Mota LJ, Borrego MJ, Gomes JP, Vaz WL, Vieira OV.

Antimicrob Agents Chemother. 2016 May 23;60(6):3323-32. doi: 10.1128/AAC.00166-16. Print 2016 Jun.

8.

The Salmonella effector SteA binds phosphatidylinositol 4-phosphate for subcellular targeting within host cells.

Domingues L, Ismail A, Charro N, Rodríguez-Escudero I, Holden DW, Molina M, Cid VJ, Mota LJ.

Cell Microbiol. 2016 Jul;18(7):949-69. doi: 10.1111/cmi.12558. Epub 2016 Mar 11.

PMID:
26676327
9.
10.

Bacterial nucleators: actin' on actin.

Bugalhão JN, Mota LJ, Franco IS.

Pathog Dis. 2015 Dec;73(9):ftv078. doi: 10.1093/femspd/ftv078. Epub 2015 Sep 27. Review.

11.

Chlamydia trachomatis In Vivo to In Vitro Transition Reveals Mechanisms of Phase Variation and Down-Regulation of Virulence Factors.

Borges V, Pinheiro M, Antelo M, Sampaio DA, Vieira L, Ferreira R, Nunes A, Almeida F, Mota LJ, Borrego MJ, Gomes JP.

PLoS One. 2015 Jul 24;10(7):e0133420. doi: 10.1371/journal.pone.0133420. eCollection 2015.

12.

Approaches targeting the type III secretion system to treat or prevent bacterial infections.

Charro N, Mota LJ.

Expert Opin Drug Discov. 2015 Apr;10(4):373-87. doi: 10.1517/17460441.2015.1019860. Epub 2015 Mar 1. Review.

PMID:
25727140
13.

The Salmonella effector SteA contributes to the control of membrane dynamics of Salmonella-containing vacuoles.

Domingues L, Holden DW, Mota LJ.

Infect Immun. 2014 Jul;82(7):2923-34. doi: 10.1128/IAI.01385-13. Epub 2014 Apr 28.

14.

Identification of type III secretion substrates of Chlamydia trachomatis using Yersinia enterocolitica as a heterologous system.

da Cunha M, Milho C, Almeida F, Pais SV, Borges V, Maurício R, Borrego MJ, Gomes JP, Mota LJ.

BMC Microbiol. 2014 Feb 17;14:40. doi: 10.1186/1471-2180-14-40.

15.

Identification of novel type III secretion chaperone-substrate complexes of Chlamydia trachomatis.

Pais SV, Milho C, Almeida F, Mota LJ.

PLoS One. 2013;8(2):e56292. doi: 10.1371/journal.pone.0056292. Epub 2013 Feb 19.

16.

Salmonella inhibits retrograde trafficking of mannose-6-phosphate receptors and lysosome function.

McGourty K, Thurston TL, Matthews SA, Pinaud L, Mota LJ, Holden DW.

Science. 2012 Nov 16;338(6109):963-7. doi: 10.1126/science.1227037. Erratum in: Science. 2012 Dec 7;338(6112):1287.

17.

Polymorphisms in inc proteins and differential expression of inc genes among Chlamydia trachomatis strains correlate with invasiveness and tropism of lymphogranuloma venereum isolates.

Almeida F, Borges V, Ferreira R, Borrego MJ, Gomes JP, Mota LJ.

J Bacteriol. 2012 Dec;194(23):6574-85. doi: 10.1128/JB.01428-12. Epub 2012 Oct 5.

18.

Bacteria and protozoa differentially modulate the expression of Rab proteins.

Seixas E, Ramalho JS, Mota LJ, Barral DC, Seabra MC.

PLoS One. 2012;7(7):e39858. doi: 10.1371/journal.pone.0039858. Epub 2012 Jul 20.

19.

Salmonella-induced tubular networks.

Schroeder N, Mota LJ, Méresse S.

Trends Microbiol. 2011 Jun;19(6):268-77. doi: 10.1016/j.tim.2011.01.006. Epub 2011 Feb 23. Review.

PMID:
21353564
20.

SCAMP3 is a component of the Salmonella-induced tubular network and reveals an interaction between bacterial effectors and post-Golgi trafficking.

Mota LJ, Ramsden AE, Liu M, Castle JD, Holden DW.

Cell Microbiol. 2009 Aug;11(8):1236-53. doi: 10.1111/j.1462-5822.2009.01329.x. Epub 2009 Apr 27.

21.

Membrane dynamics and spatial distribution of Salmonella-containing vacuoles.

Ramsden AE, Holden DW, Mota LJ.

Trends Microbiol. 2007 Nov;15(11):516-24. Epub 2007 Nov 5. Review.

PMID:
17983751
22.

Probing key DNA contacts in AraR-mediated transcriptional repression of the Bacillus subtilis arabinose regulon.

Franco IS, Mota LJ, Soares CM, de Sá-Nogueira I.

Nucleic Acids Res. 2007;35(14):4755-66. Epub 2007 Jul 7.

23.

The SPI-2 type III secretion system restricts motility of Salmonella-containing vacuoles.

Ramsden AE, Mota LJ, Münter S, Shorte SL, Holden DW.

Cell Microbiol. 2007 Oct;9(10):2517-29. Epub 2007 Jun 7.

24.

The discovery of SycO highlights a new function for type III secretion effector chaperones.

Letzelter M, Sorg I, Mota LJ, Meyer S, Stalder J, Feldman M, Kuhn M, Callebaut I, Cornelis GR.

EMBO J. 2006 Jul 12;25(13):3223-33. Epub 2006 Jun 22.

26.

Type III secretion gets an LcrV tip.

Mota LJ.

Trends Microbiol. 2006 May;14(5):197-200. Epub 2006 Mar 24. Review.

PMID:
16564172
27.

FlAsHlights on bacterial virulence proteins.

Mota LJ, Holden DW.

Nat Methods. 2005 Dec;2(12):898-9. No abstract available.

PMID:
16299473
28.

Type III secretion: the bacteria-eukaryotic cell express.

Mota LJ, Sorg I, Cornelis GR.

FEMS Microbiol Lett. 2005 Nov 1;252(1):1-10. Epub 2005 Sep 8. Review.

29.

The bacterial injection kit: type III secretion systems.

Mota LJ, Cornelis GR.

Ann Med. 2005;37(4):234-49. Review.

PMID:
16019722
30.

Characterization of a Type III secretion substrate specificity switch (T3S4) domain in YscP from Yersinia enterocolitica.

Agrain C, Callebaut I, Journet L, Sorg I, Paroz C, Mota LJ, Cornelis GR.

Mol Microbiol. 2005 Apr;56(1):54-67.

31.

Bacterial injectisomes: needle length does matter.

Mota LJ, Journet L, Sorg I, Agrain C, Cornelis GR.

Science. 2005 Feb 25;307(5713):1278.

32.

Identification of a nuclear targeting signal in YopM from Yersinia spp.

Benabdillah R, Mota LJ, Lützelschwab S, Demoinet E, Cornelis GR.

Microb Pathog. 2004 May;36(5):247-61.

PMID:
15043860
33.

Transcriptional regulation of genes encoding arabinan-degrading enzymes in Bacillus subtilis.

Raposo MP, Inácio JM, Mota LJ, de Sá-Nogueira I.

J Bacteriol. 2004 Mar;186(5):1287-96.

34.
35.

Effect of low- and high-virulence Yersinia enterocolitica strains on the inflammatory response of human umbilical vein endothelial cells.

Denecker G, Tötemeyer S, Mota LJ, Troisfontaines P, Lambermont I, Youta C, Stainier I, Ackermann M, Cornelis GR.

Infect Immun. 2002 Jul;70(7):3510-20.

36.
37.

Mode of action of AraR, the key regulator of L-arabinose metabolism in Bacillus subtilis.

Mota LJ, Tavares P, Sá-Nogueira I.

Mol Microbiol. 1999 Aug;33(3):476-89.

38.

Supplemental Content

Support Center